Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Biochem Funct ; 28(5): 381-6, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20535839

RESUMO

Telomeres are essential for chromosome stability and the regulation of the replicative life-span of somatic cells. Many studies showed that exogenous telomeric repeats could activate p53 protein. It is not known how cell dysfunction is induced by telomeric plasmids. A covalent closed circular (ccc) double-stranded plasmid containing (TTAGGG)(96) repeats (pRST5) was transiently transfected into the human gastric cancer MGC-803 cells. We first confirmed that the cell viabilities decreased by 27%, cell senescence increased by 62% and G2/M cycle arrested in pRST5 plasmid transfected cells. Compared to control groups, cells transfected with telomeric plasmids showed an ATM-dependent increasing of p53, TRF1, and TRF2 expression. Furthermore, telomere dysfunction-induced foci (TIF) were observed. In conclusion, telomeric plasmids can elicit endogenous telomere dysfunction and induce cell senescence by activating ATM-p53 pathway.


Assuntos
Proteínas de Ciclo Celular/metabolismo , Senescência Celular , Proteínas de Ligação a DNA/metabolismo , Plasmídeos/genética , Proteínas Serina-Treonina Quinases/metabolismo , Telômero/química , Proteínas Supressoras de Tumor/metabolismo , Proteínas Mutadas de Ataxia Telangiectasia , Divisão Celular , Linhagem Celular Tumoral , Fase G2 , Humanos , Interferência de RNA , RNA Interferente Pequeno , Neoplasias Gástricas/metabolismo , Telômero/metabolismo , Proteína 1 de Ligação a Repetições Teloméricas/metabolismo , Proteína 2 de Ligação a Repetições Teloméricas/metabolismo , Transfecção , Proteína Supressora de Tumor p53/metabolismo
2.
J Gastroenterol ; 44(5): 460-9, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19333544

RESUMO

BACKGROUND: Our previous studies demonstrated that p53-induced gene 11 (PIG11) was involved in arsenic trioxide (As(2)O(3))-induced apoptosis in human gastric cancer MGC-803 cells. Here, we studied further PIG11 expression in human hepatocellular carcinoma (HCC) tissues and cell lines and compared the sensitivity to As(2)O(3)-induced cell apoptosis in HepG2 and L-02 cells. METHODS: PIG11 expression in human normal liver tissues, HCC tissues, and cell lines was determined by immunohistochemistry and immunocytochemistry methods, using an anti-human PIG11 antibody. Cell viability was estimated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diplenyltetrazolium bromide (MTT) assay. Cell apoptosis was determined by flow cytometry. Reverse-transcriptase polymerase chain reaction (RT-PCR) and Western blotting were performed to analyze PIG11 mRNA and protein expression in cells. Protein intensity was calculated by comparison with the intensity of beta-actin, using densitometry. PIG11 was knocked down using small interfering RNA (siRNA). RESULTS: We found that PIG11 expression was significantly downregulated in HCC tissue and the cell lines (Bel-7402, SMMC-7721, HepG2 cells). Further, HepG2 cells were more sensitive to As(2)O(3)-induced apoptosis than L-02 cells. The expression of PIG11 mRNA and protein was upregulated to a greater extent in HepG2 than in L-02 cells. In the presence of actinomycin D or cycloheximide, the amount of PIG11 protein expression did not increase. Likewise, the inhibition of PIG11 by siRNA decreased As(2)O(3)-induced PIG11 protein expression by more than 85% and partially prevented As(2)O(3)-induced apoptosis in both HepG2 and L-02 cells. CONCLUSION: The above results demonstrated that the PIG11 gene may be involved in As(2)O(3)-induced apoptosis in HepG2 cells and suggested that the adaptive response of PIG11 expression is one of the important factors in enhancing cell sensitivity to As(2)O(3)-induced apoptosis.


Assuntos
Apoptose/genética , Arsenicais/farmacologia , Carcinoma Hepatocelular/genética , Genes Supressores de Tumor/fisiologia , Neoplasias Hepáticas/genética , Proteínas de Neoplasias/genética , Óxidos/farmacologia , Adulto , Apoptose/efeitos dos fármacos , Trióxido de Arsênio , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patologia , Linhagem Celular Tumoral , Criança , Cicloeximida/farmacologia , Dactinomicina/farmacologia , Regulação para Baixo , Feminino , Expressão Gênica , Técnicas de Silenciamento de Genes , Humanos , Imuno-Histoquímica , Fígado/metabolismo , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/metabolismo , Inibidores da Síntese de Ácido Nucleico/farmacologia , Inibidores da Síntese de Proteínas/farmacologia
3.
Pathol Oncol Res ; 15(3): 411-6, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19096915

RESUMO

PIG11 (p53-induced gene 11) is a p53 target gene and candidate tumour suppressor gene. In this study, the expression of PIG11 protein was detected in human hepatocellular carcinoma (HCC) and normal liver tissues with an immunohistochemical method. Compared with expression in human normal liver tissues, the expression of PIG11 protein was significantly down-regulated in human HCC tissues. In addition, a recombinant pLXSN-PIG11 retroviral vector was constructed and transfected into HepG2 cells (human hepatocellular carcinoma cell line) and the role of PIG11 in apoptosis was analyzed. The percentage (18.60%) of apoptotic cells transfected with pLXSN-PIG11 was higher than that in cells transfected with pLXSN only (6.03%) or the vehicle control (3.81%) (P < 0.01). DNA gel electrophoresis showed a clear DNA ladder in pLXSN-PIG11-infected HepG2 cells. Our results suggested that the PIG11 gene is involved in carcinogenesis and development of hepatocarcinoma. Therefore, PIG11 is considered to be a new candidate liver tumour suppressor gene, and may play an important role in tumour suppression through promotion of cell apoptosis.


Assuntos
Apoptose/fisiologia , Carcinoma Hepatocelular/metabolismo , Neoplasias Hepáticas/metabolismo , Proteínas de Neoplasias/biossíntese , Western Blotting , Carcinoma Hepatocelular/patologia , Separação Celular , Citometria de Fluxo , Genes Supressores de Tumor , Células Hep G2 , Humanos , Processamento de Imagem Assistida por Computador , Imuno-Histoquímica , Neoplasias Hepáticas/patologia , Transfecção
4.
Biochem Biophys Res Commun ; 379(1): 70-5, 2009 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-19073141

RESUMO

We study the unfolding of a parallel G-quadruplex from human telomeric DNA by mechanical stretching using steered molecular dynamics (MD) simulation. We find that the force curves and unfolding processes strongly depend on the pulling sites. With pulling sites located on the sugar-phosphate backbone, the force-extension curve shows a single peak and the unfolding proceeds sequentially. Pulling sites located on the terminal nucleobases lead to a force-extension curve with two peaks and the unfolding is more cooperative. Simulations of the refolding of partially unfolded quadruplexes show very different behavior for the two different pulling modalities. In particular, starting from an unfolded state prepared by nucleobase pulling leads to a long-lived intermediate state whose existence is also corroborated by the free energy profile computed with the Jarzynski equation. Based on this observation, we propose a novel folding pathway for parallel G-quadruplexes with the human telomere sequence.


Assuntos
Simulação por Computador , DNA/química , Quadruplex G , Modelos Químicos , Telômero/química , Sequência de Bases , Humanos , Fenômenos Mecânicos , Conformação de Ácido Nucleico
5.
Biochem Biophys Res Commun ; 358(1): 29-34, 2007 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-17482569

RESUMO

PIG11 (p53-induced protein 11), one of early transcriptional targets of tumor suppressor p53, was up-regulated in the induction of apoptosis or cell growth inhibition by multiple chemopreventive agents. However, its biological role remains unclear. Here, we expressed His(6)-tagged PIG11 protein in Escherichia coli and demonstrated the recombinant His(6)-tagged PIG11 protein could bind to supercoiled and relaxed closed circular plasmid DNA or linear DNA with different length using gel retardation assays in vitro. The interaction between DNA and PIG11 protein was sequence-independent and related to charge effect. The reducing thiol group in PIG11 protein was involved in the binding activity of PIG11 to DNA. Furthermore, the images of atomic force microscopy directly confirmed the binding of DNA and PIG11 protein and showed the PIG11-DNA complex formed a beads-on-a-string appearance in which PIG11 protein associated with DNA as polymer. These findings suggest that PIG11 protein may play an important role by interaction with other biological molecules in the regulation of apoptosis and provided us a novel angel of view to explore the possible function of PIG11 in vivo.


Assuntos
DNA/química , Proteínas de Neoplasias/química , Conformação de Ácido Nucleico , Humanos , Microscopia de Força Atômica , Plasmídeos , Ligação Proteica , Proteínas Recombinantes/química
6.
Langmuir ; 23(8): 4486-93, 2007 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-17358085

RESUMO

Atomic force microscopy (AFM) is known to be capable of measuring local surface charge density based on the DLVO model. However, it has failed to distinguish charge density difference between the extracellular and cytoplasmic sides of purple membrane (PM) in previous studies. In this paper, tapping-mode AFM with thioglycolate-modified tips was used to image PM in buffers of different salt concentrations. When imaged in 25 mM KCl buffer, the topography of membranes appeared to be of two different types, one flat and the other domelike. Such a difference was not observed in buffers of high salt concentrations. This suggests that the topography variation results from differences in electrostatic interaction between the AFM tip and the different membrane surfaces. With images of papain-digested PM and high-resolution images of membrane surface structure, we proved that the membrane surfaces with flat topography were on the extracellular side while the surfaces with domelike topography were on the cytoplasmic side. Hence, this provides a straightforward method to distinguish the two sides of PM without the requirement of high-resolution imaging. Force-distance curves clearly demonstrated the different tip-sample interactions. The force curves recorded on the extracellular side of PM were consistent with the DLVO model, so its surface charge density can be estimated well. However, the curves recorded on the cytoplasmic side had a much longer decay length, which is supposed to be relevant to the flexibility of the C-terminus of bacteriorhodopsin (bR).


Assuntos
Bacteriorodopsinas/química , Biofísica/métodos , Microscopia de Força Atômica/instrumentação , Membrana Purpúrea/química , Físico-Química/métodos , Citoplasma/metabolismo , Halobacterium salinarum/metabolismo , Concentração de Íons de Hidrogênio , Microscopia de Força Atômica/métodos , Conformação Molecular , Estrutura Molecular , Papaína/química , Cloreto de Potássio/química , Estrutura Terciária de Proteína , Sais/farmacologia , Eletricidade Estática , Propriedades de Superfície
7.
Eur J Pharmacol ; 516(1): 1-9, 2005 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-15904916

RESUMO

In this work, our study focused on As(2)O(3) action in view point of telomere. Results showed that treatment of human gastric cancer MGC-803 cells with arsenic trioxide could cause up-regulation of telomeric repeat binding factor TRF1 and TRF2 mRNA and protein levels, and induced G2/M phase arrest and cell apoptosis. At the same time, telomere length shortening and telomerase inhibitory were not obvious. Flow cytometry measurements indicated that the increase of TRF1 and TRF2 proteins is related to oxidative stress by arsenic trioxide. Results also indicate that after arsenic trioxide treatment, p53 protein levels increased significantly and also could bind directly at the telomere t-loop junction. These findings demonstrate arsenic trioxide-induced cell cycle arrest and apoptosis might involve a novel pathway related to TRF1, TRF2 protein.


Assuntos
Arsenicais/farmacologia , Óxidos/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Proteína 1 de Ligação a Repetições Teloméricas/genética , Proteína 2 de Ligação a Repetições Teloméricas/genética , 8-Hidroxi-2'-Desoxiguanosina , Acetilcisteína/farmacologia , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Trióxido de Arsênio , Western Blotting , Ciclo Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Desoxiguanosina/análogos & derivados , Desoxiguanosina/biossíntese , Citometria de Fluxo , Fase G2/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Microscopia de Força Atômica , Ligação Proteica/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Telômero/genética , Telômero/metabolismo , Proteína 1 de Ligação a Repetições Teloméricas/metabolismo , Proteína 2 de Ligação a Repetições Teloméricas/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Regulação para Cima
8.
Mol Cell Biochem ; 269(1-2): 37-47, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15786715

RESUMO

The role of homocysteine for store-operated calcium influx was investigated in human umbilical cord endothelial cell line. Homocysteine significantly decreased thapsigargin-evoked Ca2+ entry, membrane hyperpolarization and actin polymerization. GSH and DTT prevented homocysteine-induced inhibition of thapsigargin-evoked Ca2+ entry, membrane hyperpolarization and actin polymerization; while GSSG had the opposite effect. Homocysteine blocked large conductance Ca2+-activated K+ (BK(Ca)) channels in a concentration-dependent manner and related to the redox status of the endothelial cells. BK(Ca) channels opener NS1619 reversed thapsigargin-evoked Ca2+ entry, membrane hyperpolarization and actin polymerization; BK(Ca) channels inhibitor iberiotoxin had the opposite effect. The findings suggest that homocysteine is involved in store-regulated Ca2+ entry through membrane potential-dependent and actin cytoskeleton-dependent mechanisms, redox status of homocysteine and BK(Ca) channels may play a regulatory role in it.


Assuntos
Citoesqueleto de Actina/metabolismo , Cálcio/metabolismo , Endotélio Vascular/fisiologia , Homocisteína/farmacologia , Canais de Potássio Cálcio-Ativados/antagonistas & inibidores , Sinalização do Cálcio/efeitos dos fármacos , Citoesqueleto/metabolismo , Ditiotreitol/farmacologia , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Glutationa/farmacologia , Dissulfeto de Glutationa/farmacologia , Humanos , Potenciais da Membrana/efeitos dos fármacos , Tapsigargina/farmacologia
9.
Pharmacology ; 74(2): 57-64, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15677884

RESUMO

OBJECTIVE: High levels of homocysteine (Hcy) induce a sustained injury on arterial endothelial cells, which accelerates the development of thrombosis and atherosclerosis. Hcy specifically inhibits the growth of endothelial cells. The present study investigated the signaling pathways underlying this cell-cycle effect. METHODS: Human umbilical venous endothelial cells were treated with Hcy, and/or LY294002, okadaic acid, peroxovanadate (PV), antisense Akt, phosphorylation of Akt and FKHRL1 proteins. p27(kip1) protein levels were measured with Western blotting, and Akt kinase activity and cell cycle were measured with immunoprecipitation and flow cytometry, respectively. RESULTS: We demonstrate that Hcy induces dephosphorylation of Akt and FKHRL1 and upregulates the cyclin-dependent kinase inhibitors p27(kip1) in a time- and dose-dependent manner. Phosphatidylinositol-3 kinase (PI3K) activator PV and phosphatase 2A inhibitor okadaic acid could reverse it, which suggests it was dependent on PI3K activity. Moreover, Hcy induces cell cycle G1 phase arrest prevented by pretreatment with PV and okadaic acid. Transfection with specific antisense oligonucleotides to Akt further proves the observations. CONCLUSIONS: The studies implied that a novel signaling pathway, PI3K/Akt/FOXO, might play an important role in mediating cell cycle G1 arrest in endothelial cells.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Células Endoteliais/efeitos dos fármacos , Fase G1/efeitos dos fármacos , Homocisteína/farmacologia , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Fatores de Transcrição/metabolismo , Western Blotting , Linhagem Celular , Células Endoteliais/citologia , Células Endoteliais/metabolismo , Proteína Forkhead Box O1 , Proteína Forkhead Box O3 , Fatores de Transcrição Forkhead , Homocisteína/química , Humanos , Imunoprecipitação , Isomerismo , Fosforilação , Proteínas Proto-Oncogênicas c-akt , Transdução de Sinais/efeitos dos fármacos
10.
Clin Chim Acta ; 347(1-2): 103-9, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15313147

RESUMO

BACKGROUND: Developing kinetic rate assay kit for alpha-L-fucosidase (AFU) by using a novel substrate 2-chloro-4-nitrophenyl-alpha-L-fucopyranoside (CNPF) and clinical implication in the diagnosis of hepatocellular carcinoma (HCC). METHODS: We have evaluated the new kinetic rate assay kit using a novel substrate for serum AFU employing Hitachi 7170 automated analyzer. The reaction was carried out at 37 degrees C, monitoring the wavelength at 405 nm. Serum samples from 884 Chinese subjects including 518 healthy adults and 366 patients were determined using this kit. RESULTS: The linearity was observed up to 300 U/L. The intra-assay precision (n=10) was S.D. 0.47; CV 2.6 (AFU activity, 17.8 U/L), S.D. 0.31; CV 0.79% (AFU activity, 39.71 U/L) and S.D. 0.79; CV 0.77% (AFU activity, 102 U/L). The day-to-day assay precision (n=10) was 3.96% (AFU activity: 41.1 U/L). There was no significant interference of various substances such as ascorbic acid (6 g/L), hemoglobin (220 mg/L) and bilirubin (200 mg/L). Serum AFU value for healthy adults was estimated at 22.8+/-7.1 U/L. No significant difference was found between male and female groups (p>0.05). The mean value of serum AFU activity in patients with HCC was significantly higher than in patients with cirrhosis, chronic hepatitis, other malignant neoplasm, other diseases and control subjects. No significant differences were found between controls and patients with cirrhosis, chronic hepatitis, patients, other malignant neoplasm and other diseases. The sensitivity and specificity was 81.5% and 85.4%, respectively. CONCLUSIONS: Serum alpha-L-fucosidase is a useful maker in the diagnosis of HCC. The assay had high sensitivity and specificity. The procedure determined is simple, rapid, convenient, and can be adapted to automated clinical analyzers for use in large-scale screening for early diagnosis of HCC.


Assuntos
Carcinoma Hepatocelular/enzimologia , Glucosídeos , Neoplasias Hepáticas/enzimologia , Nitrocompostos , alfa-L-Fucosidase/sangue , Adulto , Idoso , Idoso de 80 Anos ou mais , Algoritmos , Biomarcadores Tumorais , Colorimetria , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Hidrólise , Cinética , Masculino , Pessoa de Meia-Idade , Kit de Reagentes para Diagnóstico , Valores de Referência , Espectrofotometria Ultravioleta
11.
FEBS Lett ; 569(1-3): 94-8, 2004 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-15225615

RESUMO

The tumor suppressor p53 regulates the expression of various genes that promote apoptosis. PIG11 (P53-induced gene 11), also referred to as TP53I11 (tumor protein p53 inducible protein 11), is a direct p53 target gene. Recent data demonstrated that PIG11 was up-regulated markedly in arsenic trioxide induced apoptosis by DDRT-PCR, suggesting a new class of p53 target genes that sensitize cells to the effects of chemotherapeutic agents. In this study, through the construction of a recombinant GFP-PIG11 expression vector and transfection of HEK293 cells with GFP or GFP-PIG11, the role of PIG11 in apoptosis was analyzed. Results demonstrated that the percentage (11.38%) of apoptotic cells with GFP-PIG11 transfection was higher than that (7.28%) of with only GFP transfection (P<0.05). At 24 h after 1 microM of arsenic trioxide treatment, apoptotic cells exhibited a significant increase in the expression of GFP-PIG11 (36.67%+/-2.78), in contrast, 10.50%+/-2.03 only GFP and 5.25%+/-0.96 vehicle control (P<0.01). In addition, we showed that intracellular content of reactive oxygen species (ROS) was 9.66+/-0.52 in GFP-PIG11 transfection, higher than 5.21+/-0.08 in GFP only and 5.99+/-0.45 in vehicle control (P<0.01). The above results suggest that overexpression of PIG11 could induce cell apoptosis in the low levels and enhanced the apoptotic effects of arsenic trioxide. The process could be involved in intracellular generation of ROS.


Assuntos
Regulação da Expressão Gênica/fisiologia , Genes p53/genética , Óxidos/toxicidade , Proteínas/genética , Apoptose/efeitos dos fármacos , Trióxido de Arsênio , Arsenicais , Sequência de Bases , Linhagem Celular , Sequência Consenso , Humanos , Rim , Proteínas de Neoplasias , Regiões Promotoras Genéticas/genética , Proteínas/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Proteínas Recombinantes/metabolismo , Transfecção
12.
Eur J Pharmacol ; 474(2-3): 141-7, 2003 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-12921855

RESUMO

In this work, we investigated the synergic effects between low-dose arsenic trioxide and diethyloxadicarbocyanine (DODC), a telomerase inhibitor, on cell apoptosis. Results revealed that low-dose arsenic could block cell cycle arrest at the G2/M phase and induce apoptosis, whereas DODC could block cell cycle arrest at the G0/G1 phase but not induce apoptosis. However, cells pretreated with DODC showed greater sensitivity to arsenic than untreated cells. The percentage of apoptosis produced by combination treatment with the two agents increased and that was similar to the effect of high-dose arsenic treatment alone. Further studies showed that DODC alone could induce hairpin G-quadruplex formation and inhibit telomerase activity in a dose-dependent manner. Compared with HT1080 cells, 293 cells were more sensitive to cell growth inhibition and apoptosis and were less sensitivity to telomerase activity. These results indicate that DODC can synergistically enhance the apoptosis induced by arsenic, suggesting the increased cell senescence in response to arsenic is induced by an altered telomere state rather than by a loss of telomerase. Thus clinical application of combination treatment with arsenic and telomerase inhibitor may have potential in cancer therapy.


Assuntos
Apoptose/efeitos dos fármacos , Arsenicais/farmacologia , Óxidos/farmacologia , Telômero/efeitos dos fármacos , Apoptose/fisiologia , Trióxido de Arsênio , Linhagem Celular , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Inibidores do Crescimento/farmacologia , Humanos , Telomerase/antagonistas & inibidores , Telomerase/metabolismo , Telômero/fisiologia
13.
Oncol Rep ; 10(5): 1265-9, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12883691

RESUMO

Arsenic trioxide (As2O3) has been used as an effective chemotherapy agent for some human cancer, such as acute promyelocytic leukemia. We have demonstrated that low level of As2O3 relatively selectively inhibited growth of the solid tumor MGC-803 cells by triggering apoptosis. In this study, we found PIG11, a p53-induced gene, was upregulated markedly by As2O3 using the technique of differential display reverse transcriptase PCR (DDRT-PCR). Addition of anti-PIG11 phosphorothioated oligonucleotide (5'-GGC CGC CAT CTT CTC CTC-3') before As2O3 treatment, abolished the transient increase in PIG11 gene expression. Furthermore, it significantly inhibited the As2O3-induced apoptosis of MGC-803 cells, but had no effect in addition of missense (5'-GAG GAG AAG ATG GCG GCC-3') phosphorothioated oligonucleotides. These results suggest that PIG11, as a downstream target of p53, is involved in apoptosis of MGC-803 cells.


Assuntos
Apoptose , Arsenicais , Carcinógenos , Óxidos , Proteínas , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patologia , Proteína Supressora de Tumor p53/genética , Proteína Supressora de Tumor p53/metabolismo , Trióxido de Arsênio , Linhagem Celular Tumoral , Clonagem Molecular , Perfilação da Expressão Gênica , Humanos , Mutação de Sentido Incorreto , Proteínas de Neoplasias , Oligonucleotídeos/química , Oligonucleotídeos Antissenso/química , RNA/química , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Neoplasias Gástricas/induzido quimicamente , Proteína Supressora de Tumor p53/fisiologia , Regulação para Cima
14.
J Cardiovasc Pharmacol ; 42(2): 258-65, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12883331

RESUMO

Homocystinemia has been identified as an independent risk factor for atherosclerosis. Monocyte chemoattractant protein-l (MCP-l) is a potent chemokine that stimulates the migration of monocytes into the intima of the arterial wall. The authors investigated the role of intracellular redox status in the expression of MCP-l stimulated by homocysteine in endothelial cells. Homocysteine stimulated MCP-1 mRNA expression and protein production in a time-dependent and dose-dependent manner in endothelial cells, decreased intracellular glutathione (GSH) and protein thiol levels, as well as G6PDH activity and NADPH levels. Thiol reduced reagents, GSH, and dithiothreitol levels, and reversed the MCP-l mRNA expression and protein production in endothelial cells; in addition, thiol oxidized reagent, diamide, and BSO levels, and markedly potentiated homocysteine-mediated up-regulation of MCP-l mRNA expression and protein production in endothelial cells. These results demonstrate that homocysteine can trigger overexpression of the MCP-1 gene by altering the intracellular redox status, suggesting that the homocysteine-induced changes in the intracellular redox status play an important role in modulating the expression of MCP-l in endothelial cells.


Assuntos
Quimiocina CCL2/metabolismo , Endotélio Vascular/efeitos dos fármacos , Homocisteína/farmacologia , Células Cultivadas , Quimiocina CCL2/genética , Endotélio Vascular/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Glutationa/metabolismo , Humanos , NADP/metabolismo , Oxirredução/efeitos dos fármacos
15.
J Biomol Struct Dyn ; 20(5): 693-702, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12643772

RESUMO

The telomeric DNA oligomers, d(TTAGGG)(n), where n=1, 2, 4, could self-associate into the multi-stranded structures in appropriate condition, exhibited different CD spectra. The presense of Na(+) was more advantage to facilitate the formation of anti-parallel conformation, but the presense of K(+) enhanced their thermal stability. Spectroscopic analysis of 3, 3'-diethyloxadicarbocyanine (DODC) showed the formation of hairpin quadruplex structures for d(TTAGGG)(2) and d(TTAGGG)(4), but d(TTAGGG) could not. The four-stranded tetraplexes and branched nanowire formed in the presense of K(+) or Na(+) alone were observed by atomic force microscopy (AFM). The ability of d(TTAGGG)(n) to self-assemble into four-stranded tetraplexes and nanowires depends strongly on the number of repeating units and ionic environment. A model to explain how these structures formed is proposed.


Assuntos
DNA/química , Potássio/farmacologia , Sódio/farmacologia , Telômero/química , Cátions Monovalentes/química , Dicroísmo Circular , Quadruplex G , Microscopia de Força Atômica , Modelos Químicos , Oligonucleotídeos/química , Sequências de Repetição em Tandem
16.
Eur J Pharmacol ; 448(1): 11-8, 2002 Jul 12.
Artigo em Inglês | MEDLINE | ID: mdl-12126965

RESUMO

We have investigated the action of oxidative stress in arsenite-induced apoptosis of human gastric cancer MGC-803 cells. Cells exhibited obvious characteristic of apoptosis following the treatment with 1.0 microM arsenite for 24 h. During the process, low concentration of arsenite significantly increased superoxide formation and lipid peroxidation, which was dose-dependent and was related to cell apoptosis induced by arsenite. The oxidant-dependent increase in intracellular [Ca(2+)] level and p53 gene expression were also observed at the same time. A phospholipase C inhibitor, 1-[6-([(17 beta)-3-methoxyestra-1,3,5,(10)-trien-17-yl]-amino)hexyl]-2,5-dione (U73122), could block the rapid transient increase in intracellular Ca(2+) levels, as well as the subsequent fragmentation of nuclear DNA. Addition of alpha-tocopherol before arsenite treatment abolished the transient increase in superoxide formation, lipid peroxidation, intracellular [Ca(2+)] levels and p53 gene expression, and furthermore could significantly inhibited the arsenite-induced apoptosis of MGC-803 cells. These results indicate that arsenite-induced oxidative stress, which stimulate cellular signaling systems, are involved in apoptosis of MGC-803 cells.


Assuntos
Arsenitos/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Espécies Reativas de Oxigênio , alfa-Tocoferol/farmacologia , Apoptose , Cálcio/metabolismo , DNA/efeitos dos fármacos , Interações Medicamentosas , Humanos , Superóxidos/metabolismo , Células Tumorais Cultivadas
17.
Pharmacology ; 64(3): 160-8, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11834893

RESUMO

Opposite biological effects of arsenic trioxide (As(2)O(3)) and arsacetin on the growth of human gastric cancer MGC-803 cells have been observed. Results show that As(2)O(3) inhibited the growth of MGC-803 cells by triggering apoptosis, whereas arsacetin promoted the cell proliferation and seemed to stimulate the secretion of some growth factors at the same micromolar concentrations. Further studies showed that As(2)O(3) could regulate protein tyrosine kinase activity, protein tyrosine phosphorylation, and Bcl-2 protein and upregulate p53 protein. The ability of arsacetin to promote cell proliferation is linked with causing the opposite effects on these factors. These results indicate that the opposite biological effects of As(2)O(3) and arsacetin involve different regulations of molecular mechanisms in MGC-803 cells and that arsacetin may be a potential tumor promoter.


Assuntos
Arsenicais/farmacologia , Inibidores Enzimáticos/farmacologia , Óxidos/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas Tirosina Quinases/metabolismo , Transdução de Sinais , Apoptose/efeitos dos fármacos , Trióxido de Arsênio , Ciclo Celular/efeitos dos fármacos , Fragmentação do DNA/efeitos dos fármacos , Ativação Enzimática , Humanos , Fosforilação/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patologia , Células Tumorais Cultivadas , Proteína Supressora de Tumor p53/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...